Premier Debt to Equity Ratio 2012-2024 | PINC
Current and historical debt to equity ratio values for Premier (PINC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Premier debt/equity for the three months ending September 30, 2024 was 0.00.
| Premier Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-09-30 | $1.36B | $1.95B | 0.70 |
| 2024-06-30 | $1.44B | $1.96B | 0.73 |
| 2024-03-31 | $1.44B | $1.92B | 0.75 |
| 2023-12-31 | $1.44B | $2.39B | 0.60 |
| 2023-09-30 | $1.50B | $2.35B | 0.64 |
| 2023-06-30 | $1.04B | $2.33B | 0.44 |
| 2023-03-31 | $1.18B | $2.34B | 0.50 |
| 2022-12-31 | $1.23B | $2.31B | 0.54 |
| 2022-09-30 | $1.16B | $2.26B | 0.51 |
| 2022-06-30 | $1.11B | $2.25B | 0.49 |
| 2022-03-31 | $1.28B | $2.23B | 0.57 |
| 2021-12-31 | $1.17B | $2.28B | 0.52 |
| 2021-09-30 | $1.24B | $2.33B | 0.53 |
| 2021-06-30 | $1.29B | $2.23B | 0.58 |
| 2021-03-31 | $1.47B | $2.22B | 0.66 |
| 2020-12-31 | $1.34B | $2.17B | 0.62 |
| 2020-09-30 | $1.31B | $2.14B | 0.61 |
| 2020-06-30 | $1.09B | $1.86B | 0.59 |
| 2020-03-31 | $1.26B | $1.80B | 0.70 |
| 2019-12-31 | $0.95B | $1.67B | 0.57 |
| 2019-09-30 | $0.90B | $1.69B | 0.54 |
| 2019-06-30 | $0.91B | $1.66B | 0.55 |
| 2019-03-31 | $1.05B | $1.64B | 0.64 |
| 2018-12-31 | $0.94B | $1.70B | 0.55 |
| 2018-09-30 | $0.83B | $1.68B | 0.50 |
| 2018-06-30 | $0.82B | $1.49B | 0.55 |
| 2018-03-31 | $0.90B | $1.40B | 0.64 |
| 2017-12-31 | $0.87B | $1.45B | 0.60 |
| 2017-09-30 | $0.99B | $1.51B | 0.66 |
| 2017-06-30 | $1.03B | $1.48B | 0.70 |
| 2017-03-31 | $4.01B | $-1.41B | -2.85 |
| 2016-12-31 | $3.96B | $-1.35B | -2.94 |
| 2016-09-30 | $0.67B | $1.22B | 0.55 |
| 2016-06-30 | $0.67B | $1.19B | 0.57 |
| 2016-03-31 | $0.71B | $1.15B | 0.61 |
| 2015-12-31 | $0.71B | $1.08B | 0.66 |
| 2015-09-30 | $0.69B | $1.01B | 0.68 |
| 2015-06-30 | $0.57B | $0.96B | 0.59 |
| 2015-03-31 | $0.55B | $0.94B | 0.59 |
| 2014-12-31 | $0.54B | $0.89B | 0.61 |
| 2014-09-30 | $0.46B | $0.82B | 0.56 |
| 2014-06-30 | $0.47B | $0.77B | 0.61 |
| 2014-03-31 | $0.48B | $0.72B | 0.66 |
| 2013-12-31 | $0.46B | $0.63B | 0.73 |
| 2013-09-30 | $0.24B | $0.28B | 0.84 |
| 2013-06-30 | $0.21B | $0.39B | 0.55 |
| 2013-03-31 | $0.00B | $0.00B | 0.00 |
| 2012-12-31 | $0.00B | $0.00B | 0.00 |
| 2012-09-30 | $0.00B | $0.00B | 0.00 |
| 2012-06-30 | $0.20B | $0.36B | 0.55 |
| 2011-06-30 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.271B | $1.346B |
| Premier, Inc. operates as a healthcare alliance. The company brings together hospitals, health systems, physicians and other healthcare providers primarily in the United States. It also maintains clinical, financial and outcomes databases. Premier, Inc. is headquartered in Charlotte, North Carolina. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $96.890B | 12.02 |
| Cencora (COR) | United States | $46.107B | 17.62 |
| DiDi Global (DIDIY) | China | $23.233B | 0.00 |
| ICON (ICLR) | Ireland | $18.679B | 16.64 |
| Revvity (RVTY) | United States | $15.535B | 26.63 |
| Avantor (AVTR) | United States | $15.498B | 23.24 |
| Natera (NTRA) | United States | $15.385B | 0.00 |
| Viatris (VTRS) | United States | $13.858B | 4.22 |
| BioMerieux (BMXMF) | France | $13.601B | 0.00 |
| Solventum (SOLV) | United States | $12.636B | 0.00 |
| CochLear (CHEOY) | Australia | $12.565B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.202B | 28.74 |
| Charles River Laboratories (CRL) | United States | $9.742B | 18.41 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| HealthEquity (HQY) | United States | $7.792B | 42.29 |
| Doximity (DOCS) | United States | $7.787B | 49.34 |
| Bausch + Lomb (BLCO) | Canada | $6.975B | 32.47 |
| Life Times (LTH) | United States | $4.762B | 31.52 |
| PACS (PACS) | United States | $4.502B | 0.00 |
| Sotera Health (SHC) | United States | $4.367B | 23.36 |
| Organon (OGN) | United States | $4.239B | 4.28 |
| Surgery Partners (SGRY) | United States | $3.778B | 41.86 |
| BrightSpring Health Services (BTSG) | United States | $3.070B | 65.30 |
| Ardent Health Partners (ARDT) | United States | $2.577B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.546B | 0.00 |
| Concentras Parent (CON) | United States | $2.480B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.254B | 84.86 |
| GeneDx Holdings (WGS) | United States | $2.057B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.575B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
| Progyny (PGNY) | United States | $1.425B | 25.06 |
| Establishment Labs Holdings (ESTA) | $1.338B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.319B | 12.91 |
| CareDx (CDNA) | United States | $1.228B | 0.00 |
| Agilon Health (AGL) | United States | $1.123B | 0.00 |
| Embecta (EMBC) | United States | $0.864B | 5.76 |
| InnovAge Holding (INNV) | United States | $0.822B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.722B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.488B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.483B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| DocGo (DCGO) | United States | $0.355B | 13.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.309B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
| ModivCare (MODV) | United States | $0.232B | 7.37 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Biodesix (BDSX) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.178B | 0.00 |
| MultiPlan (MPLN) | United States | $0.136B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.35 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.63 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.021B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |